140 related articles for article (PubMed ID: 8878590)
1. Efficacy of sparfloxacin and autoradiographic diffusion pattern of [14C]Sparfloxacin in experimental Staphylococcus aureus joint prosthesis infection.
Crémieux AC; Mghir AS; Bleton R; Manteau M; Belmatoug N; Massias L; Garry L; Sales N; Mazière B; Carbon C
Antimicrob Agents Chemother; 1996 Sep; 40(9):2111-6. PubMed ID: 8878590
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of teicoplanin and autoradiographic diffusion pattern of [14C]teicoplanin in experimental Staphylococcus aureus infection of joint prostheses.
Saleh Mghir A; Crémieux AC; Bleton R; Ismael F; Manteau M; Dautrey S; Massias L; Garry L; Sales N; Mazière B; Carbon C
Antimicrob Agents Chemother; 1998 Nov; 42(11):2830-5. PubMed ID: 9797211
[TBL] [Abstract][Full Text] [Related]
3. Comparison of sparfloxacin, temafloxacin, and ciprofloxacin for prophylaxis and treatment of experimental foreign-body infection by methicillin-resistant Staphylococcus aureus.
Cagni A; Chuard C; Vaudaux PE; Schrenzel J; Lew DP
Antimicrob Agents Chemother; 1995 Aug; 39(8):1655-60. PubMed ID: 7486895
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and ocular penetration of sparfloxacin in experimental streptococcal endophthalmitis.
Cochereau-Massin I; Bauchet J; Marrakchi-Benjaafar S; Saleh-Mghir A; Faurisson F; Vallois JM; Vallee E; Pocidalo JJ
Antimicrob Agents Chemother; 1993 Apr; 37(4):633-6. PubMed ID: 8388193
[TBL] [Abstract][Full Text] [Related]
5. Systemic prophylaxis of experimental staphylococcal endophthalmitis: comparative efficacy of sparfloxacin, pefloxacin, imipenem, vancomycin, and amikacin.
Marrakchi-Benjaafar S; Cochereau I; Pocidalo JJ; Carbon C
J Infect Dis; 1995 Nov; 172(5):1312-6. PubMed ID: 7594669
[TBL] [Abstract][Full Text] [Related]
6. Sparfloxacin therapy for experimental endocarditis caused by methicillin-resistant Staphylococcus aureus.
Maserati R; Cagni AE; Segú C
Chemotherapy; 1996; 42(2):133-9. PubMed ID: 8697888
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of temafloxacin in experimental Streptococcus adjacens endocarditis and autoradiographic diffusion pattern of [14C]temafloxacin in cardiac vegetations.
Cremieux AC; Saleh-Mghir A; Vallois JM; Maziere B; Muffat-Joly M; Devine C; Bouvet A; Pocidalo JJ; Carbon C
Antimicrob Agents Chemother; 1992 Oct; 36(10):2216-21. PubMed ID: 1332590
[TBL] [Abstract][Full Text] [Related]
8. Ceftaroline-Fosamil efficacy against methicillin-resistant Staphylococcus aureus in a rabbit prosthetic joint infection model.
Gatin L; Saleh-Mghir A; Tasse J; Ghout I; Laurent F; Crémieux AC
Antimicrob Agents Chemother; 2014 Nov; 58(11):6496-500. PubMed ID: 25136014
[TBL] [Abstract][Full Text] [Related]
9. Teicoplanin-containing cement spacers for treatment of experimental Staphylococcus aureus joint prosthesis infection.
Ismael F; Bléton R; Saleh-Mghir A; Dautrey S; Massias L; Crémieux AC
Antimicrob Agents Chemother; 2003 Oct; 47(10):3365-7. PubMed ID: 14506060
[TBL] [Abstract][Full Text] [Related]
10. Treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus with a biodegradable system of lactic acid polymer releasing pefloxacin.
Kanellakopoulou K; Galanakis N; Giamarellos-Bourboulis EJ; Rifiotis C; Papakostas K; Andreopoulos A; Dounis E; Karagianakos P; Giamarellou H
J Antimicrob Chemother; 2000 Aug; 46(2):311-4. PubMed ID: 10933660
[TBL] [Abstract][Full Text] [Related]
11. Parenteral sparfloxacin compared with ceftriaxone in treatment of experimental endocarditis due to penicillin-susceptible and -resistant streptococci.
Entenza JM; Blatter M; Glauser MP; Moreillon P
Antimicrob Agents Chemother; 1994 Dec; 38(12):2683-8. PubMed ID: 7695248
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of (99m)Tc-ciprofloxacin scintigraphy in a rabbit model of Staphylococcus aureus prosthetic joint infection.
Sarda L; Saleh-Mghir A; Peker C; Meulemans A; Crémieux AC; Le Guludec D
J Nucl Med; 2002 Feb; 43(2):239-45. PubMed ID: 11850491
[TBL] [Abstract][Full Text] [Related]
13. Antibacterial activity of sparfloxacin against experimental renal infections in mice.
Georgopoulos A; Feistauer SM; Graninger W; Pfleger S; Georgopoulos M
Antimicrob Agents Chemother; 1992 Feb; 36(2):505-7. PubMed ID: 1318685
[TBL] [Abstract][Full Text] [Related]
14. Correlates of therapeutic efficacy in experimental methicillin-resistant Staphylococcus aureus endocarditis.
Bayer AS; Greenberg DP; Yih J
Chemotherapy; 1988; 34(1):46-55. PubMed ID: 3162413
[TBL] [Abstract][Full Text] [Related]
15. Sparfloxacin and clinafloxacin alone or in combination with gentamicin for therapy of experimental ampicillin-resistant enterococcal endocarditis in rabbits.
Vazquez J; Perri MB; Thal LA; Donabedian SA; Zervos MJ
J Antimicrob Chemother; 1993 Nov; 32(5):715-21. PubMed ID: 8125836
[TBL] [Abstract][Full Text] [Related]
16. Activities of trovafloxacin compared with those of other fluoroquinolones against purified topoisomerases and gyrA and grlA mutants of Staphylococcus aureus.
Gootz TD; Zaniewski RP; Haskell SL; Kaczmarek FS; Maurice AE
Antimicrob Agents Chemother; 1999 Aug; 43(8):1845-55. PubMed ID: 10428901
[TBL] [Abstract][Full Text] [Related]
17. [In vitro activity of sparfloxacin against methicillin-resistant staphylococci].
Wallrauch C; Voss A; Milatovic D; Braveny I
Arzneimittelforschung; 1995 Jun; 45(6):723-5. PubMed ID: 7646580
[TBL] [Abstract][Full Text] [Related]
18. Combination of quinupristin-dalfopristin (Synercid) and rifampin is highly synergistic in experimental Staphylococcus aureus joint prosthesis infection.
Saleh-Mghir A; Ameur N; Muller-Serieys C; Ismael F; Lemaitre F; Massias L; Feger C; Bléton R; Crémieux AC
Antimicrob Agents Chemother; 2002 Apr; 46(4):1122-4. PubMed ID: 11897604
[TBL] [Abstract][Full Text] [Related]
19. In vitro evaluation of sparfloxacin activity and spectrum against 24,940 pathogens isolated in the United States and Canada, the final analysis.
Jones RN; Ballow CH; Schentag JJ; Johnson DM; Deinhart JA
Diagn Microbiol Infect Dis; 1998 May; 31(1):313-25. PubMed ID: 9597392
[TBL] [Abstract][Full Text] [Related]
20. Role of protein D2 and lipopolysaccharide in diffusion of quinolones through the outer membrane of Pseudomonas aeruginosa.
Michéa-Hamzehpour M; Furet YX; Pechère JC
Antimicrob Agents Chemother; 1991 Oct; 35(10):2091-7. PubMed ID: 1662023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
